These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H, Sigsgaard T, Wolf H, Autrup H. Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [Abstract] [Full Text] [Related]
8. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K. Mutat Res; 2005 Jul 01; 574(1-2):112-23. PubMed ID: 15914211 [Abstract] [Full Text] [Related]
11. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer. Brockmöller J, Kaiser R, Kerb R, Cascorbi I, Jaeger V, Roots I. Pharmacogenetics; 1996 Dec 01; 6(6):535-45. PubMed ID: 9014203 [Abstract] [Full Text] [Related]
19. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer. Giannakopoulos X, Charalabopoulos K, Baltogiannis D, Chatzikiriakidou A, Alamanos Y, Georgiou I, Evangelou A, Agnantis N, Sofikitis N. Anticancer Res; 2002 Dec 01; 22(6B):3801-4. PubMed ID: 12552997 [Abstract] [Full Text] [Related]
20. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM. Int J Hyg Environ Health; 2003 Jun 01; 206(3):149-71. PubMed ID: 12872524 [Abstract] [Full Text] [Related] Page: [Next] [New Search]